Grekova T I, Kireeva L A, Shaĭdarova V A, Trufanova G I, Bobrova T V, Kravtsov V I, Ostretsov E E
Eksp Klin Farmakol. 1994 Jul-Aug;57(4):31-3.
Finoptin in a dose of 0,145 mg/kg prevented cardiomyocytic immune disorders in dogs and rats with cardiogenic shock of immune genesis. In test systems, the drug and nifedipine reduced the immune lysis in the cells by the complement.
剂量为0.145毫克/千克的芬诺普汀可预防免疫源性心源性休克犬和大鼠的心肌细胞免疫紊乱。在测试系统中,该药物和硝苯地平可减少补体对细胞的免疫溶解作用。